183 related articles for article (PubMed ID: 17662267)
1. Crosstalk between the p190-B RhoGAP and IGF signaling pathways is required for embryonic mammary bud development.
Heckman BM; Chakravarty G; Vargo-Gogola T; Gonzales-Rimbau M; Hadsell DL; Lee AV; Settleman J; Rosen JM
Dev Biol; 2007 Sep; 309(1):137-49. PubMed ID: 17662267
[TBL] [Abstract][Full Text] [Related]
2. p190-B RhoGAP regulates mammary ductal morphogenesis.
Chakravarty G; Hadsell D; Buitrago W; Settleman J; Rosen JM
Mol Endocrinol; 2003 Jun; 17(6):1054-65. PubMed ID: 12637587
[TBL] [Abstract][Full Text] [Related]
3. P190-B Rho GTPase-activating protein overexpression disrupts ductal morphogenesis and induces hyperplastic lesions in the developing mammary gland.
Vargo-Gogola T; Heckman BM; Gunther EJ; Chodosh LA; Rosen JM
Mol Endocrinol; 2006 Jun; 20(6):1391-405. PubMed ID: 16469769
[TBL] [Abstract][Full Text] [Related]
4. P190A RhoGAP is required for mammary gland development.
Heckman-Stoddard BM; Vargo-Gogola T; Herrick MP; Visbal AP; Lewis MT; Settleman J; Rosen JM
Dev Biol; 2011 Dec; 360(1):1-10. PubMed ID: 21945077
[TBL] [Abstract][Full Text] [Related]
5. P190-B, a Rho-GTPase-activating protein, is differentially expressed in terminal end buds and breast cancer.
Chakravarty G; Roy D; Gonzales M; Gay J; Contreras A; Rosen JM
Cell Growth Differ; 2000 Jul; 11(7):343-54. PubMed ID: 10939588
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780.
Chan TW; Pollak M; Huynh H
Clin Cancer Res; 2001 Aug; 7(8):2545-54. PubMed ID: 11489838
[TBL] [Abstract][Full Text] [Related]
7. Decreased IGF type 1 receptor signaling in mammary epithelium during pregnancy leads to reduced proliferation, alveolar differentiation, and expression of insulin receptor substrate (IRS)-1 and IRS-2.
Sun Z; Shushanov S; LeRoith D; Wood TL
Endocrinology; 2011 Aug; 152(8):3233-45. PubMed ID: 21628386
[TBL] [Abstract][Full Text] [Related]
8. BMP4 and PTHrP interact to stimulate ductal outgrowth during embryonic mammary development and to inhibit hair follicle induction.
Hens JR; Dann P; Zhang JP; Harris S; Robinson GW; Wysolmerski J
Development; 2007 Mar; 134(6):1221-30. PubMed ID: 17301089
[TBL] [Abstract][Full Text] [Related]
9. The mouse mammary gland requires the actin-binding protein gelsolin for proper ductal morphogenesis.
Crowley MR; Head KL; Kwiatkowski DJ; Asch HL; Asch BB
Dev Biol; 2000 Sep; 225(2):407-23. PubMed ID: 10985859
[TBL] [Abstract][Full Text] [Related]
10. Targeted disruption of the IGF-I receptor gene decreases cellular proliferation in mammary terminal end buds.
Bonnette SG; Hadsell DL
Endocrinology; 2001 Nov; 142(11):4937-45. PubMed ID: 11606462
[TBL] [Abstract][Full Text] [Related]
11. Terminal end bud maintenance in mammary gland is dependent upon FGFR2b signaling.
Parsa S; Ramasamy SK; De Langhe S; Gupte VV; Haigh JJ; Medina D; Bellusci S
Dev Biol; 2008 May; 317(1):121-31. PubMed ID: 18381212
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development.
Ruan W; Kleinberg DL
Endocrinology; 1999 Nov; 140(11):5075-81. PubMed ID: 10537134
[TBL] [Abstract][Full Text] [Related]
13. Lef1 is required for the transition of Wnt signaling from mesenchymal to epithelial cells in the mouse embryonic mammary gland.
Boras-Granic K; Chang H; Grosschedl R; Hamel PA
Dev Biol; 2006 Jul; 295(1):219-31. PubMed ID: 16678815
[TBL] [Abstract][Full Text] [Related]
14. Developmental and hormonal signals dramatically alter the localization and abundance of insulin receptor substrate proteins in the mammary gland.
Lee AV; Zhang P; Ivanova M; Bonnette S; Oesterreich S; Rosen JM; Grimm S; Hovey RC; Vonderhaar BK; Kahn CR; Torres D; George J; Mohsin S; Allred DC; Hadsell DL
Endocrinology; 2003 Jun; 144(6):2683-94. PubMed ID: 12746333
[TBL] [Abstract][Full Text] [Related]
15. Modulation of Rho GTPase signaling regulates a switch between adipogenesis and myogenesis.
Sordella R; Jiang W; Chen GC; Curto M; Settleman J
Cell; 2003 Apr; 113(2):147-58. PubMed ID: 12705864
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor 1 receptor signaling regulates skin development and inhibits skin keratinocyte differentiation.
Sadagurski M; Yakar S; Weingarten G; Holzenberger M; Rhodes CJ; Breitkreutz D; Leroith D; Wertheimer E
Mol Cell Biol; 2006 Apr; 26(7):2675-87. PubMed ID: 16537911
[TBL] [Abstract][Full Text] [Related]
17. IGF-I: an essential factor in terminal end bud formation and ductal morphogenesis.
Kleinberg DL; Feldman M; Ruan W
J Mammary Gland Biol Neoplasia; 2000 Jan; 5(1):7-17. PubMed ID: 10791764
[TBL] [Abstract][Full Text] [Related]
18. Disruption of steroid and prolactin receptor patterning in the mammary gland correlates with a block in lobuloalveolar development.
Grimm SL; Seagroves TN; Kabotyanski EB; Hovey RC; Vonderhaar BK; Lydon JP; Miyoshi K; Hennighausen L; Ormandy CJ; Lee AV; Stull MA; Wood TL; Rosen JM
Mol Endocrinol; 2002 Dec; 16(12):2675-91. PubMed ID: 12456789
[TBL] [Abstract][Full Text] [Related]
19. Dual regulation of upstream binding factor 1 levels by IRS-1 and ERKs in IGF-1-receptor signaling.
Sun H; Tu X; Liu M; Baserga R
J Cell Physiol; 2007 Sep; 212(3):780-6. PubMed ID: 17443674
[TBL] [Abstract][Full Text] [Related]
20. Decreased lactation capacity and altered milk composition in insulin receptor substrate null mice is associated with decreased maternal body mass and reduced insulin-dependent phosphorylation of mammary Akt.
Hadsell DL; Olea W; Lawrence N; George J; Torres D; Kadowaki T; Lee AV
J Endocrinol; 2007 Aug; 194(2):327-36. PubMed ID: 17641282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
